Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AKT as a Therapeutic Target for Cancer
Mengqiu Song, Ann M. Bode, Zigang Dong, et al.
Cancer Research (2019) Vol. 79, Iss. 6, pp. 1019-1031
Closed Access | Times Cited: 646

Showing 51-75 of 646 citing articles:

Chitosan-coated magnetic graphene oxide for targeted delivery of doxorubicin as a nanomedicine approach to treat glioblastoma
Banendu Sunder Dash, Yu‐Jen Lu, Ya‐Shu Huang, et al.
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129401-129401
Closed Access | Times Cited: 11
UPP1 enhances bladder cancer progression and gemcitabine resistance through AKT
Wenzhi Du, Sheng Tu, Wenxiu Zhang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 4, pp. 1389-1409
Open Access | Times Cited: 10
Curcumin in Cancer and Inflammation: An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management
Dong‐Oh Moon
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2911-2911
Open Access | Times Cited: 9
TRIM22 induces cellular senescence by targeting PHLPP2 in hepatocellular carcinoma
Donghee Kang, Hyun Jung Hwang, Yurim Baek, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Highlights in Resistance Mechanism Pathways for Combination Therapy
João Marcos de Azevedo Delou, A. S. Souza, Leonel Cardozo de Menezes e Souza, et al.
Cells (2019) Vol. 8, Iss. 9, pp. 1013-1013
Open Access | Times Cited: 73
Genome-wide germline correlates of the epigenetic landscape of prostate cancer
Kathleen E. Houlahan, Yu-Jia Shiah, Alexander Gusev, et al.
Nature Medicine (2019) Vol. 25, Iss. 10, pp. 1615-1626
Open Access | Times Cited: 62
Role of Akt Activation in PARP Inhibitor Resistance in Cancer
Ferenc Gallyas, Balázs Sümegi, Csaba Szabó
Cancers (2020) Vol. 12, Iss. 3, pp. 532-532
Open Access | Times Cited: 62
Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer
Camilla Evangelisti, Francesca Chiarini, Francesca Paganelli, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2019) Vol. 1867, Iss. 4, pp. 118635-118635
Open Access | Times Cited: 60
RETRACTED ARTICLE: PI3K/Akt pathway and Nanog maintain cancer stem cells in sarcomas
Changhwan Yoon, Jun Lü, Brendan C. Yi, et al.
Oncogenesis (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 53
Effects of chitosan and oligochitosans on the phosphatidylinositol 3-kinase-AKT pathway in cancer therapy
Elaheh Amirani, Jamal Hallajzadeh, Zatollah Asemi, et al.
International Journal of Biological Macromolecules (2020) Vol. 164, pp. 456-467
Closed Access | Times Cited: 50
Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness
Chao Jing, Yuansheng Duan, Mengqian Zhou, et al.
Theranostics (2021) Vol. 11, Iss. 6, pp. 2655-2669
Open Access | Times Cited: 50
Dual target inhibitors based on EGFR: Promising anticancer agents for the treatment of cancers (2017-)
Liping Hu, Mengmeng Fan, Shengmin Shi, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113963-113963
Closed Access | Times Cited: 45
Immune Landscape of CMV Infection in Cancer Patients: From “Canonical” Diseases Toward Virus-Elicited Oncomodulation
Ranim El Baba, Georges Herbein
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 44
Combined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis
Xiaolong Tang, Guo Li, Lei Shi, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 41
The IRF2/CENP-N/AKT signaling axis promotes proliferation, cell cycling and apoptosis resistance in nasopharyngeal carcinoma cells by increasing aerobic glycolysis
Chenglin Qi, Mao‐Ling Huang, You Zou, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 40
Mechanisms of Resistance and Implications for Treatment Strategies in Chronic Myeloid Leukaemia
Govinda Poudel, Molly G. Tolland, Timothy P. Hughes, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3300-3300
Open Access | Times Cited: 36
Targeting Oncogenic Pathways in the Era of Personalized Oncology: A Systemic Analysis Reveals Highly Mutated Signaling Pathways in Cancer Patients and Potential Therapeutic Targets
Alexandros Karagiannakos, Maria Adamaki, Antonis Tsintarakis, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 664-664
Open Access | Times Cited: 35
Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy
Jianya Huan, Petros Grivas, Jasmine Birch, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1555-1555
Open Access | Times Cited: 30
Prolactin: The Third Hormone in Breast Cancer
Linda A. Schuler, Kathleen A. O’Leary
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 29
Neural stem cell‑derived exosomes transfer miR‑124‑3p into cells to inhibit glioma growth by targeting FLOT2
Qian Cheng, You Wang, Yunxiang Ji, et al.
International Journal of Oncology (2022) Vol. 61, Iss. 4
Open Access | Times Cited: 28
CTSG Suppresses Colorectal Cancer Progression through Negative Regulation of Akt/mTOR/Bcl2 Signaling Pathway
Shixin Chan, Xu Wang, Zhenglin Wang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 7, pp. 2220-2233
Open Access | Times Cited: 19
Computational drug repurposing of Akt-1 allosteric inhibitors for non-small cell lung cancer
Krishnaprasad Baby, Swastika Maity, Chetan Hasmukh Mehta, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Cereblon-Recruiting PROTACs: Will New Drugs Have to Face Old Challenges?
Marcin Cieślak, Marta Słowianek
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 812-812
Open Access | Times Cited: 17
Anti-apoptosis effect of traditional Chinese medicine in the treatment of cerebral ischemia–reperfusion injury
Nan Zhao, Yuhe Gao, Hongtao Jia, et al.
APOPTOSIS (2023) Vol. 28, Iss. 5-6, pp. 702-729
Closed Access | Times Cited: 17
Protein Kinase B (PKB/AKT) Protects IDH-Mutated Glioma from Ferroptosis via Nrf2
Yang Liu, Fu-Ju Chou, Fengchao Lang, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 7, pp. 1305-1316
Open Access | Times Cited: 16

Scroll to top